Bayer is committed to helping you with insurance, financial or affordability challenges.

Take advantage of all that Access Services by Bayer can offer, including:

Patient Loyalty Program hands interlocked graphic.

Patient Loyalty Program†§

Bayer is committed to helping you start and stay on therapy regardless of changes in your commercial health insurance coverage status.

Eligible patients can receive Jivi® at no cost if you experience gaps or changes with insurance coverage.

Free Trial Program calendar graphic.

Free Trial Program‡§

All patients new to Jivi can receive 1 month of free therapy.

  • The selected product is delivered to your home.
  • Any patient new to Jivi is able to participate, regardless of insurance type or status.
Zero dollar co-pay program phone operator graphic.

$0 Co-Pay Program*†

  • Most commercially insured patients can receive Jivi for as little as $0 per prescription, regardless of income* (up to $20,000 in co-pay assistance per year.)
  • Assistance is awarded per patient. Multiple members of the same household can apply.
Enroll online

Hear Stacey share how Access Services by Bayer helps her family manage the cost of her son's treatment.

Access services by Bayer logo.

this checklist and complete the next steps of enrollment with your physician.

Speak with a health insurance expert. Live helpline support and multiple languages, including Spanish, are available.

IF YOU DO NOT HAVE INSURANCE

Bayer US Patient Assistance Foundation is a charitable organization that helps eligible patients get Bayer prescription medicine at no cost.

Please contact the program at 1-866-228-7723 Monday-Friday, 
9:00 AM-6:00 PM (ET), or visit the foundation website at 
www.patientassistance.bayer.us 
for information to see if you qualify for assistance.

INDICATIONS

Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A.

Jivi is used to treat and control bleeding in previously treated adults and adolescents (12 years of age and older) with hemophilia A. Your healthcare provider may also give you Jivi when you have surgery. Jivi can reduce the number of bleeding episodes in adults and adolescents with hemophilia A when used regularly (prophylaxis).

Jivi is not for use in children below 12 years of age or in previously untreated patients.

Jivi is not used to treat von Willebrand disease.

IMPORTANT SAFETY INFORMATION

You should not use Jivi if you are allergic to rodents (like mice and hamsters) or to any ingredients in Jivi.

Tell your healthcare provider about all of your medical conditions that you have or had.

Tell your healthcare provider if you have been told that you have inhibitors to Factor VIII.

Allergic reactions may occur with Jivi. Call your healthcare provider right away and stop treatment if you get tightness of the chest or throat, dizziness, decrease in blood pressure, or nausea.

Allergic reactions to polyethylene glycol (PEG), a component of Jivi, are possible.

Your body can also make antibodies, called “inhibitors,” against Jivi, which may stop Jivi from working properly. Consult your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to Factor VIII.

If your bleeding is not being controlled with your usual dose of Jivi, consult your doctor immediately. You may have developed Factor VIII inhibitors or antibodies to PEG and your doctor may carry out tests to confirm this.

The common side effects of Jivi are headache, cough, nausea, and fever.

These are not all the possible side effects with Jivi. Tell your healthcare provider about any side effect that bothers you or that does not go away.

For additional important risk and use information, please see the full Prescribing Information.